Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Age of Menarche and Final Height in Patients With Permanent Congenital Hypothyroidism Publisher



Karimian P1 ; Hovsepian S2, 3 ; Alinia T2 ; Raispour H2 ; Mirshahzadeh N4 ; Hashemipour M2, 4
Authors
Show Affiliations
Authors Affiliations
  1. 1. School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Metabolic Liver Disease Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Imam Hossein Children's Hospital, Isfahan University of Medical Sciences, Isfahan, Iran
  4. 4. Isfahan Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Annals of Pediatric Endocrinology and Metabolism Published:2024


Abstract

Purpose: We compared the age at menarche and standard deviation score (SDS) of final height (FH) in permanent congenital hypothyroidism (CH) patients with those of healthy female adolescents and assessed their associations with CH screening-related variables or demographic factors. Methods: In this cross-sectional study, we included 207 female CH patients and 598 healthy age-matched female adolescents. Ages at puberty onset and menarche, height at puberty and menarche, and the FH and its SDS were evaluated in the 2 groups and compared. Associations between screening variables and anthropometric data with age at menarche and SDS of FH were also assessed in CH patients. Results: In the included population, 113 patients with CH and 453 healthy girls attained their FH. The mean ages at puberty onset and menarche in CH patients were higher than those in the healthy population (P<0.05). The mean height at menarche and the FH and its SDS were not different between the 2 groups (P>0.05). There was no significant association between FH SDS in CH patients and age of treatment (P=0.30). Age at menarche was significantly higher in CH patients with delayed age at treatment initiation (P=0.04). The difference between FH and target height was not significantly different among CH patients (P=0.83). Conclusion: While CH patients had a significantly higher age at menarche compared to the healthy population, appropriate treatment changed this age to be similar to that in the healthy group. However, CH patients who experienced delayed treatment had a higher age at menarche. Age at treatment initiation was the only screening-related variable related to age at onset of menarche and puberty. © 2024 Annals of Pediatric Endocrinology & Metabolism.
Other Related Docs
9. Prevalence of Permanent Congenital Hypothyroidism in Isfahan-Iran, International Journal of Preventive Medicine (2013)
13. Congenital Hypothyroidism; Is There Any Familial Component?, Journal of Isfahan Medical School (2009)
26. Age of Puberty in a Representative Sample of Iranian Girls, World Journal of Pediatrics (2009)
28. Isfahan Thyroid Cohort Study (Itcs), Archives of Iranian Medicine (2021)
30. Guideline for the Treatment of Hypothyroidism in Prematurity, International Journal of Preventive Medicine (2021)
31. Age of Menarche and Its Related Factors in School Girls of Shahrekord, Journal of Isfahan Medical School (2009)
32. Spatial Distribution of Congenital Hypothyroidism, Archives of Iranian Medicine (2021)
34. The Role of Ultrasonography in Primary Congenital Hypothyroidism, Journal of Research in Medical Sciences (2011)